Multi-centre, Prospective, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Treatment of Pulmonary Arterial Hypertension With Vardenafil in China (EVALUATION)

NCT00718952 Phase 3 COMPLETED

The purpose of this study is to evaluate the efficacy and safety of vardenafil in the treatment of pulmonary arterial hypertension.

Details

Lead sponsor	Tongji University
Phase	Phase 3
Status	COMPLETED
Enrolment	60
Start date	2008-07
Completion	2010-02

Conditions

• Pulmonary Hypertension

Interventions

• Vardenafil
• Placebo
• Vardenafil

Primary outcomes

• The change in exercise capacity, as measured by the total distance walked in six minutes — at week 12 and week 24

Countries

China